Skip to main content
Enter your The Contraceptive Pipeline Database username.
Enter the password that accompanies your username.
May 30, 2018
Active Pharmaceutical Ingredient (API):
Potential Multi-Purpose Technology (MPT):
Proven to be a safe, and effective contraceptive (in combination with diaphragm) in Phase III trials.
Intended to block HIV-infected cells, herpes, HPV, gonorrhea, and chlamydia in animal models, but failed to show efficacy in clinical trial.
Compatible with condoms and diaphragms.
Polymers of acrylic acid cross-linked with polyalkenyl ethers or divinyl glycol
Download Product Report